Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: Importance of polymer degradation and antigen release for immune response

Journal of Controlled Release

Volumn 41, Issue 1-2, 1996, Pages 131-145

  Thomasin, Claudio ^a   Corradin, Giampietro ^b   Men, Ying ^b   Merkle, Hans P ^a   Gander, Bruno ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Antigen release; Biodegradable microspheres; Immune responses; Poly(lactide) (PLA); Poly(lactide co glycolide) (PLGA); Polymer degradation; Synthetic malaria antigen; Tetanus toxoid

Indexed keywords

ALUMINUM POTASSIUM SULFATE; FREUND ADJUVANT; MALARIA ANTIGEN; MICROSPHERE; OVOTHIN 170; PEPTIDE P30B2; PHOSPHATIDYLCHOLINE; POLYGLACTIN; POLYLACTIDE; POLYMER; RESOMER R202; RESOMER R203; RESOMER R206; RESOMER RG502; RESOMER RG503; RESOMER RG752; RESOMER RG755; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY TITER; BIODEGRADATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNOPOTENTIATION; MICROENCAPSULATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030222362     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01363-6     Document Type: Conference Paper

References (44)

1. [1] M.J. Alonso, S. Cohen, T.G. Park, R.K. Gupta, G.R. Siber and R. Langer, Determinants of release rate of tetanus vaccine from polyester microspheres, Pharm. Res. 10 (1993) 945-953.
2. [2] M.J. Alonso, R.K. Gupta, C. Min, G.R. Siber and R. Langer, Biodegradable microspheres as controlled-release tetanus toxoid delivery systems, Vaccine 12 (1994) 299-306.
3. [3] Y. Men, G. Corradin, C. Thomasin, H.P. Merkle and B. Gander, Immunopotentiation of a synthetic antigen by incorporation into biodegradable microspheres, Proc. Int. Symp. Control. Rel. Bioact. Mater. 21 (1994) 50-51.
4. [4] B. Gander, C. Thomasin, H.P. Merkle, Y. Men and G. Corradin, Pulsed tetanus toxoid release from PLGA-microspheres and its relevance for immunogenicity in mice, Proc. Int. Symp. Control. Rel. Bioact. Mater. 20 (1993) 65-66.
5. [5] M.T. Aguado and P.-H. Lambert, Controlled release vaccines - Biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles, Immunobiology 184 (1992) 113-125.
6. [6] M.T. Aguado, Future approaches to vaccine development: Single-dose vaccines using controlled-release delivery systems, Vaccine 11 (1993) 596-597.
7. [7] J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley and T.R. Tice, Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches, J. Control. Release 11 (1990) 205-214.
8. [8] D.T. O'Hagan, Oral immunization and the common mucosal immune system, in: D.T. O'Hagan (Ed.), Novel Delivery Systems for Oral Vaccines, CRC Press, Boca Raton, FL, 1994, pp. 1-24.
9. [9] J. Mestecky, Z. Moldoveanu, M. Novak, W.-Q. Huang, R.M. Gilley, J.K. Staas, D. Schafer and R.W. Compans, Biodegradable microspheres for the delivery of oral vaccines, J. Control. Release 28 (1994) 131-141.
10. [10] A.J. Almeida, H.O. Alpar and M.R.W. Brown, Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs, J. Pharm. Pharmacol. 45 (1993) 198-203.
11. [11] I. Preis and R.S. Langer, A single-step immunization by sustained antigen release, J. Immunol. Methods 28 (1979) 193-197.
12. [12] J. Kohn, S.M. Niemi, E.C. Albert, J.C. Murphy, R. Langer and J.G. Fox, Single-step immunization using a controlled release biodegradable polymer with sustained adjuvant activity, J. Immunol. Methods 95 (1986) 31-38.
13. [13] L.M. Sanders, J.S. Kent, G.I. McRae, B.H. Vickery, T.R. Tice and D.H. Lewis, Controlled release of luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres, J. Pharm. Sci. 73 (1984) 1294-1297.
14. [14] G.E. Visscher, R.L. Robison, H.V. Maulding, J.W. Fong, J.E. Pearson and G.J. Argentieri, Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules, J. Biomed. Mater. Res. 19 (1985) 349-365.
15. [15] G.E. Visscher, R.L. Robison, H.V. Maulding, J.W. Fong, J.E. Pearson and G.J. Argentieri, Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules, J. Biomed. Mater. Res. 20 (1986) 667-676.
16. [16] R.A. Kenley, M.O. Lee, T.R. Mahoney II and L.M. Sanders, Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro, Macromolecules 20 (1987) 2398-2403.
17. [17] H.T. Wang, H. Palmer, R.J. Linhardt, D.R. Flanagan and E. Schmitt, Degradation of poly(ester) microspheres, Biomaterials 11 (1990) 679-685.
18. [18] S.S. Shah, Y. Cha and C.G. Pitt, Poly(glycolic acid-co-DL-lactic acid): Diffusion or degradation controlled drug delivery? J. Control. Release 18 (1992) 261-270.
19. [19] G. Rafler and M. Jobmann, Controlled release systems of biodegradable polymers. 1st communication: Hydrolytic degradation of biodegradable aliphatic polyesters, Pharm. Ind. 56 (1994) 565-570.
20. [20] T.G. Park, Degradation of poly(D,L-lactic acid) microspheres: effect of molecular weight, J. Control. Release 30 (1994) 161-173.
21. [21] D.T. O'Hagan, H. Jeffery and S.S. Davis, The preparation and characterization of poly(lactide-co-glycolide) microparticles: III Microparticle/polymer degradation rates and the in vitro release of a model protein, Int. J. Pharm. 103 (1994) 37-45.
22. [22] S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang and R. Langer, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8 (1991) 713-720.
23. [23] E.A. Schmitt, D.R. Flanagan and R.J. Linhardt, Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers, J. Pharm. Sci. 82 (1993) 326-329.
24. [24] M. Vert, S. Li and H. Garreau, More about the degradation of LA/GA-derived matrices in aqueous media, J. Control. Release 16 (1991) 15-26.
25. [25] C.G. Pitt, Non-microbial degradation of polyesters: Mechanisms and modifications, in: M. Vert, J. Feijen, A. Albertson, G. Scott and E. Chiellini (Eds.), Biodegradable Polymers and Plastics, Redwood Press, 1992, pp. 7-17.
26. [26] J.R. Lawter, N.S. Brizzolara, M.G. Lanzilotti and G.O. Morton, Drug release from poly(glycolid-co-lactide) microcapsules, Proc. Int. Symp. Control. Rel. Bioact. Mater. 14 (1987) 99-100.
27. [27] D. Bodmer, T. Kissel and E. Traechslin, Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems, J. Control. Release 21 (1992) 129-138.
28. [28] T.G. Park, W. Lu and G. Crotts, Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres, J. Control. Release 33 (1995) 211-222.
29. [29] W. Lu and T.G. Park, Protein release from poly(lactic-co-glycolic acid) microspheres: Protein stability problems, PDA J. Pharm. Sci. Technol. 49 (1995) 13-19.
30. [30] I. Esparza and T. Kissel, Parameters affecting the immunogenicity of microencapsulated tetanus toxoid, Vaccine 10 (1992) 714-720.
31. [31] M. Singh, A. Singh and G.P. Talwar, Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules, Pharm. Res. 8 (1991) 958-961.
32. [32] D. Valmori, A. Pessi, E. Bianchi, G. Corradin, Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination, J. Immunol. 149 (1992) 717-721.
33. [33] B. Gander, E. Wehrli, R. Alder and H.P. Merkle, Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection, J. Microencapsulation 12 (1995) 83-97.
34. [34] C. Thomasin, P. Johansen, R. Alder, R. Bemsel, G. Hottinger, H. Altorfer, A.D. Wright, E. Wehrli, H.P. Merkle and B. Gander, Approaching the problem of residual solvents in biodegradable microspheres prepared by coacervation, Eur. J. Pharm. Biopharm. 42 (1996) in press.
35. [35] D.W. Van Krevelen, Properties of Polymers, 3rd Ed., Elsevier, Amsterdam, The Netherlands, 1990.
36. [36] Y. Men, C. Thomasin, H.P. Merkle, B. Gander and G. Corradin, A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide, Vaccine 13 (1995) in press.
37. [37] H. Pistner, D. Bendix, J. Mühling and J. Reuther, Poly(L-lactide): A long term degradation study in vivo, Part III. Analytical characterization, Biomaterials 14 (1993) 291-298.
38. [38] R.L. Dunn, J.P. English, J.D. Strobel, D.R. Cowsar and T.R. Tice, Preparation and evaluation of lactide/glycolide copolymers for drug delivery, in: C. Migliaresi (Ed.), Polymers in Medicine III, Elsevier, Amsterdam, 1988.
39. [39] K. Makino, H. Ohshima and T. Kondo, Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration, J. Microencapsulation 3 (1986) 203-212.
40. [40] M.S. Hora, R.K. Rana, J.H. Nunberg, T.R. Tice, R.M. Gilley and M.E. Hudson, Release of human serum albumin from poly(lactide-co-glycolide) microspheres, Pharm. Res. 7 (1990) 1190-1194.
41. [41] S.P. Schwendeman, J.H. Lee, R.K. Gupta, H.R. Costantino, G.R. Siber and R. Langer, Inhibition of moisture-induced aggregation of tetanus toxoid by protecting thiol groups, Proc. Int. Symp. Control. Rel. Bioact. Mater. 21 (1994) 54-55.
42. [42] Y. Tabata and Y. Ikada, Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage, Biomaterials 9 (1988) 356-362.
43. [43] J.K. Staas, J.H. Eldridge, J.D. Morgan, O.B. Finch, T.R. Tice and R.M. Gilley, Microsphere vaccines: enhanced immune response through adjuvant effect and multiple-pulse release capability, Proc. Int. Symp. Control. Rel. Bioact. Mater. 18 (1991) 619-620.
44. [44] S. Bennett and E.M. Riley, The statistical analysis of data from immunoepidemiological studies, J. Immunol. Methods 146 (1992) 229-239.